SAM
RGNX icon

Shell Asset Management’s Regenxbio RGNX Stock Holding History

Shell Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,356
Closed -$198K – 1484
2020
Q4 		$198K Hold
4,356
– – ﹤0.01% 1116
2020
Q3 		$120K Hold
4,356
– – ﹤0.01% 1142
2020
Q2 		$160K Sell
4,356
-84
-2% -$3.13K ﹤0.01% 1069
2020
Q1 		$144K Sell
4,440
-68
-2% -$2.83K ﹤0.01% 1073
2019
Q4 		$185K Sell
4,508
-132
-3% -$5.21K ﹤0.01% 1142
2019
Q3 		$165K Sell
4,640
-40
-0.9% -$1.62K ﹤0.01% 1155
2019
Q2 		$240K Sell
4,680
-107
-2% -$5.34K 0.01% 1095
2019
Q1 		$274K Hold
4,787
– – 0.01% 1057
2018
Q4 		$201K Sell
4,787
-400
-8% -$23.5K 0.01% 1037
2018
Q3 		$392K Buy
+5,187
New +$374K 0.01% 1020

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Shell Asset Management's RGNX Position: Q1 2021 in Review

Shell Asset Management sold out of Regenxbio (RGNX) in Q1 2021, closing a stake of 4,356 shares — an estimated $198K sold.

Shell Asset Management first reported a position in RGNX in Q3 2018 and held it in 10 quarters. The position peaked at $392K in Q3 2018. 184 funds tracked by Wall St. Rank hold RGNX as of Q1 2021.

  • Shell Asset Management reported no remaining Regenxbio position as of Q1 2021 after selling out during the quarter.
  • Shell Asset Management sold 4,356 Regenxbio shares in Q1 2021, an estimated $198K.
  • Shell Asset Management first reported a position in Regenxbio in Q3 2018 and held it in 10 quarters.
  • Shell Asset Management's Regenxbio position peaked at $392K in Q3 2018.
  • 184 funds tracked by Wall St. Rank held Regenxbio as of Q1 2021.

Based on Shell Asset Management's 13F filing for Q1 2021, filed 10 May 2021.